Fosun Pharma Delivers First Locally Built Surgical Robots, Revolutionizing Medical Technology in China

Date:

Fosun Pharma, a Shanghai-based healthcare unit of Fosun International, has successfully delivered its first locally built surgical robot to clients in China. The milestone achievement is part of Fosun Pharma’s efforts to make advanced medical technology more affordable and accessible to Chinese patients. The company partnered with California-based Intuitive Surgical to establish a 700 million yuan research and production base in Shanghai.

The Da Vinci surgical system, based on artificial intelligence, allows surgeons to perform complex and minimally invasive operations from a console. It has been used in over 10 million surgeries worldwide, delivering better results and faster patient recoveries. Fosun Pharma’s delivery of the first locally built robot comes after the successful importation of 360 Da Vinci robots to local clients.

China’s growing middle-class consumer base is increasingly aware of the importance of quality healthcare, thereby driving demand for world-class medical devices and treatments. Local production of surgical robots, such as the Da Vinci system, is a significant step towards bringing best-in-class technology to Chinese patients. The Chinese government’s industrial strategy, Made in China 2025, aims to have 70% of mid-tier to high-end medical devices manufactured domestically by 2025 and 95% by 2030.

Fosun Pharma’s commitment to introducing advanced foreign medical technology and talent to China is further demonstrated by its exclusive distribution of the mRNA Covid-19 vaccine produced by German firm BioNTech. Additionally, the company has a venture with US-based Kite Pharma to supply CAR-T cell therapy products in the local market.

Other international pharmaceutical and medical device manufacturers are also looking to tap into the extensive Chinese market as Beijing opens it up to foreign goods and services. Yamada Aki, of Takeda Pharmaceuticals, believes China can accelerate her company’s development of new products, making it their third-largest foreign market.

See also  Amazon's Growth Engine Surges as Hedge Fund Titans Shift Investments

The China International Import Expo (CIIE), the world’s largest import trade show, recently concluded with a record-breaking $78.4 billion worth of deals, highlighting the increasing appetite for foreign goods and services in China. Premier Li Qiang emphasized the importance of consumer vitality and further reopening of China’s economy as potential drivers for global economic growth.

In conclusion, Fosun Pharma’s successful delivery of locally built surgical robots marks a significant milestone in China’s ambition to provide the best medical technology to its patients. With the demand for cutting-edge medical devices on the rise, the country aims to increase domestic production of these devices to meet its healthcare needs. By collaborating with international partners and enhancing its market accessibility, China is positioning itself as a major player in the global healthcare industry.

Frequently Asked Questions (FAQs) Related to the Above News

What is Fosun Pharma?

Fosun Pharma is a healthcare unit of Fosun International, based in Shanghai, China.

What is the milestone achievement of Fosun Pharma?

Fosun Pharma has successfully delivered its first locally built surgical robot to clients in China.

What is the purpose of Fosun Pharma's efforts?

The purpose of Fosun Pharma's efforts is to make advanced medical technology more affordable and accessible to Chinese patients.

Who did Fosun Pharma partner with to establish a research and production base?

Fosun Pharma partnered with California-based Intuitive Surgical to establish a research and production base in Shanghai.

What is the Da Vinci surgical system?

The Da Vinci surgical system is a robotic surgical system based on artificial intelligence, allowing surgeons to perform complex and minimally invasive operations.

How many surgeries has the Da Vinci system been used in worldwide?

The Da Vinci system has been used in over 10 million surgeries worldwide.

How does Fosun Pharma's delivery of the first locally built robot contribute to bringing advanced technology to Chinese patients?

Fosun Pharma's delivery of the first locally built robot is a significant step towards making best-in-class technology more accessible to Chinese patients.

What is China's industrial strategy related to the manufacturing of medical devices?

China's industrial strategy, Made in China 2025, aims to have 70% of mid-tier to high-end medical devices manufactured domestically by 2025 and 95% by 2030.

Apart from surgical robots, what other medical technologies does Fosun Pharma bring to China?

Fosun Pharma distributes the mRNA Covid-19 vaccine produced by German firm BioNTech and has a venture with US-based Kite Pharma to supply CAR-T cell therapy products in the local market.

Are other international pharmaceutical and medical device manufacturers also targeting the Chinese market?

Yes, other international pharmaceutical and medical device manufacturers are looking to tap into the extensive Chinese market as Beijing opens it up to foreign goods and services.

What was the outcome of the China International Import Expo (CIIE)?

The China International Import Expo (CIIE) concluded with a record-breaking $78.4 billion worth of deals, showcasing the increasing appetite for foreign goods and services in China.

How does China aim to position itself in the global healthcare industry?

With collaborations with international partners and increased domestic production, China is positioning itself as a major player in the global healthcare industry.

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Elon Musk’s Terrifying Prediction: AI Will Take Over Jobs, Harming Children’s Future

Elon Musk predicts AI will take over jobs, posing a threat to children's future. Are we ready for a world where robots replace humans?

Harvard Graduates Urged to Fight Misinformation by Nobel Peace Prize Winner

Harvard Graduates are urged by a Nobel Peace Prize Winner to combat misinformation in a powerful call to action.

Google’s Alphabet in Talks to Acquire HubSpot for $30 Billion, Boost Cloud Applications Market Competitiveness

Google's Alphabet eyes $30B HubSpot acquisition to boost cloud app market competitiveness against Microsoft.

Groundbreaking Study Reveals 150+ Genetic Variants Linked to Psychiatric Disorders

Groundbreaking study reveals 150+ genetic variants linked to psychiatric disorders using machine learning in human brain cells.